Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02285439
Title Phase I/II Study of MEK162 for Children With Ras/Raf Pathway Activated Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Children's Hospital Los Angeles , Dana-Farber Cancer Institute
Indications

Advanced Solid Tumor

Therapies

Binimetinib

Age Groups: adult | child
Covered Countries USA

Facility Status City State Zip Country Details
Children's Hospital of Alabama Birmingham Alabama 35233 United States Details
Children's Hospital Los Angeles Los Angeles California 90027 United States Details
Children's Hospital of Colorado Aurora Colorado 80045 United States Details
Children's National Heath Systems Washington District of Columbia 20010 United States Details
Nicklaus Children's Hospital Miami Florida 33155 United States Details
Children's Healthcare of Atlanta Atlanta Georgia 30322 United States Details
Johns Hopkins University Baltimore Maryland 21287 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Children's Hospitals and Clinics of Minnesota-Minneapolis Minneapolis Minnesota 55404 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
New York University New York New York 10016 United States Details
Oregon Health and Science University Portland Oregon 97239 United States Details
University of Texas Southwestern Medical Dallas Texas 75390 United States Details
Texas Children's Hospital Houston Texas 77030 United States Details
Seattle Children's Hospital Seattle Washington 98145 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field